Alger Russell Innovation ETF Rating $20.68 +0.04 (+0.19%) As of 10/14/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Alger Russell Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.INVN Aggregate RatingHold 2.37Holdings in INVN have an aggregate rating of Hold based on 513 analyst ratings issued in the past year covering 25 companies (53.3% of the portfolio).INVN Aggregate Price Target$20.68High Prediction$20.68Average Prediction$20.68Low Prediction$20.68Holdings in INVN have an aggregate price target of $20.68 and a range of $20.68 to $20.68 covering 25 companies (53.3% of the portfolio).INVN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce3 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Alger Russell Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 INVN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.51%LYFTLyft$20.13+0.7%4.0245 of 5 stars2.29$19.12 -5.0%34Trending NewsAnalyst ForecastGap Down2.39%ETSYEtsy$71.96+2.2%3.7066 of 5 stars2.26$59.35 -17.5%31Analyst ForecastGap Down2.28%CORTCorcept Therapeutics$72.12+0.8%4.9012 of 5 stars2.57$135.25 87.5%72.28%BILLBILL$49.87+0.5%4.0057 of 5 stars2.41$59.75 19.8%22Trending NewsAnalyst Forecast2.23%EAElectronic Arts$200.200.0%4.1429 of 5 stars2.16$177.00 -11.6%312.20%NTNXNutanix$67.94-1.4%4.8997 of 5 stars2.78$87.67 29.0%182.18%PATHUiPath$16.46-3.9%2.0946 of 5 stars2.06$13.21 -19.7%18Trending NewsInsider TradeGap Down2.16%GTMZoomInfo Technologies$10.26-0.2%1.3922 of 5 stars1.67$10.67 4.0%62.16%CRUSCirrus Logic$120.98+0.3%3.182 of 5 stars2.67$123.00 1.7%62.14%UTHRUnited Therapeutics$433.61-1.5%4.3904 of 5 stars2.67$457.21 5.4%152.12%HUBSHubSpot$457.60+1.7%4.6316 of 5 stars2.90$723.11 58.0%31Analyst Forecast2.12%UUnity Software$36.63-1.4%1.7577 of 5 stars2.30$32.65 -10.9%202.10%SWKSSkyworks Solutions$72.77-0.8%3.622 of 5 stars1.95$72.87 0.1%20Gap Down2.10%DBXDropbox$28.40-0.9%3.2493 of 5 stars1.75$29.67 4.5%42.09%QCOMQUALCOMM$161.740.0%4.7995 of 5 stars2.54$182.82 13.0%242.08%DOCUDocusign$68.36-1.6%4.7886 of 5 stars2.30$94.14 37.7%202.08%TDCTeradata$21.36+0.2%3.5616 of 5 stars2.00$26.86 25.8%112.05%EXELExelixis$39.51+2.8%4.771 of 5 stars2.63$44.42 12.4%24Analyst Revision2.05%WDAYWorkday$237.18+0.2%4.9542 of 5 stars2.83$287.83 21.4%35Insider Trade2.03%EXPEExpedia Group$223.12+3.5%4.1554 of 5 stars2.44$209.00 -6.3%34Positive NewsAnalyst Forecast2.02%NBIXNeurocrine Biosciences$137.23-0.1%4.8292 of 5 stars2.80$163.44 19.1%202.01%OGNOrganon & Co.$9.57-0.3%4.8089 of 5 stars2.50$17.33 81.1%62.00%NTAPNetApp$120.55+1.4%3.9712 of 5 stars2.39$121.40 0.7%18Positive NewsInsider Trade1.98%QRVOQorvo$87.87-0.1%4.198 of 5 stars2.05$95.35 8.5%19Gap Down1.97%OKTAOkta$89.08-1.2%4.8714 of 5 stars2.49$118.94 33.5%39 This page (NYSEARCA:INVN) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alger Russell Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Alger Russell Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
